SANKYO PHARMA
DEAD

Serial Number

75586071

Owner

SANKYO COMPANY LIMITED

Attorney

DAVID TOREN

Filing Date

Nov 10, 1998

Add to watchlist:

No watchlists yet
View on USPTO

SANKYO PHARMA Trademark

Serial Number: 75586071 • Registration: 2399082

SANKYO PHARMA is a trademark filed by SANKYO COMPANY LIMITED on November 10, 1998. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

SANKYO COMPANY LIMITED (114 trademarks)

CHUO-KU, TOKYO , JP

Entity Type: 03

Trademark Details

Filing Date

November 10, 1998

Registration Date

October 31, 2000

Published for Opposition

August 8, 2000

Cancellation Date

August 4, 2007

Goods & Services

Central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis; estrogen and progesterone used as combined oral contraceptives; urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria 'vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidium in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and/or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, antiparkinsonism drugs, minor tranquilizers, and antianxiety agents

Filing History

CANCELLED SEC. 8 (6-YR)
Aug 4, 2007 C8..
CASE FILE IN TICRS
Aug 10, 2006 CFIT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2006 TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 10, 2003 TCCA
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2000 R.PR
PUBLISHED FOR OPPOSITION
Aug 8, 2000 PUBO
NOTICE OF PUBLICATION
Jul 7, 2000 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2000 CNSA
EXAMINER'S AMENDMENT MAILED
Apr 7, 2000 CNEA
ASSIGNED TO EXAMINER
Mar 30, 2000 DOCK
Sec. 1(B) CLAIM DELETED
Mar 29, 2000 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 13, 1999 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 11, 1999 CRFA
NON-FINAL ACTION MAILED
Jun 7, 1999 CNRT
ASSIGNED TO EXAMINER
May 28, 1999 DOCK